RULING HAMMERS BIOVAIL

Just as storm clouds were forming above Biovail Corp. and its enigmatic chairman, the drug maker was hit with a downpour Wednesday, losing a patent infringement case that opens the door for a cheaper generic copy of its best-selling antidepressant Wellbutrin XL.

Globe and Mail (http://www.theglobeandmail.com/servlet/story/RTGAM.20060802.wbiovaill0802/BNStory/Business/home)